Brief: Burning Rock Reports Q1 Revenue RMB 135.5 Mln, Up 27.1%
31/05/2022 07:37
May 31 (Reuters) - Burning Rock Biotech Ltd BNR.O :
* BURNING ROCK REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
* SEES FY REVENUE ABOUT RMB 620 MILLION
* Q1 REVENUE ROSE 27.1 PERCENT TO RMB 135.5 MILLION
* QTRLY LOSS PER SHARE RMB 2.50
Source text for Eikon: ID:nGNX1QpbN1
Further company coverage: BNR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Burning Rock Biotech
See all newsBurning Rock Biotech's Q2 revenue falls, net loss widens on central laboratory weakness
China's Burning Rock Biotech Q1 revenue falls on lower test volumes
China's Burning Rock Biotech Q4 net loss narrows as costs fall
Cancer diagnostics firm Burning Rock Biotech's Q3 revenue rises on pharma R&D growth
Brief: Burning Rock's Oncoguide™ Oncoscreen™ Plus CDX System Now Approved In Japan As A Companion Diagnostic For Capivasertib In Breast Cancer